Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study

Table 1 Patient characteristics

	New-onset AF, no septic shock (n = 26)	New-onset AF and septic shock (n = 23)	Maintained SR and septic shock (n = 27)	P₁-value	P₂-value
Sex (f/m)	6/20	5/18	12/15	1.00	0.14
Age (years)	67 (46-84)	66 (41-85)	56 (18-80)	0.59	< 0.01
History of hypertension	16	17	11	0.38	0.02
Coronary artery disease	3	5	2	0.45	0.23
Heart failure	0	1	0	0.47	0.46
Valvular disease	0	1	1	0.47	1.00
COLD	4	4	1	1.00	0.17
Premedication
β-blocker	8	8	6	1.0	0.36
digitalis	0	1	0	0.47	0.46
Calcium antagonist	5	7	2	0.51	0.06
ACE inhibitor	10	2	7	0.02	0.15
Type of surgery
Lung surgery	4	4	2	-	-
Abdominal surgery	11	12	19	-	-
Neurosurgery	4	1	1	-	-
Traumatologic surgery	1	0	2	-	-
Vascular surgery	1	0	2	-	-
Aortic surgery	5	4	1	-	-
Others	0	2	0	-	-

Data are given as median (range in parenthesis) or as number. P₁-value, patients with new-onset atrial fibrillation (AF) without septic shock vs. septic shock patients with new-onset AF; P₂-value, septic shock patients with new-onset AF vs. septic shock patients with maintained sinus rhythm.
ACE, angiotensin-converting enzyme; COLD, chronic obstructive lung disease; f, female; m, male; SR, sinus rhythm.

ISSN: 1364-8535